Form D · Pharmaceuticals
Accelalox Inc.
Menlo Park, CA · CIK 0001474189
Offering snapshot reported Oct 9, 2009 · SEC filing
- Reported sold
- $430K Offering amount: $430K
- Investors reported
- 15 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Jan 31, 2008 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Oct 9, 2009 | Initial | $430,000 | No comparison | 15 | SEC filing |
Offering details
- Securities
- Not reported
- Exemptions
- 06
- Duration over one year
- Yes
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-135128
Source: Form D, filed Oct 9, 2009. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Julia O'connor | Director, Executive, Promoter |
| J. Patrick O'connor | Director, Executive, Promoter |
Issuer details
Industry: Pharmaceuticals (See others in industry)
Address:
325 Sharon Park Drive, #310
Menlo Park, CA, 94025
Menlo Park, CA, 94025